Avanir

Aliso Viejo, United States Founded: 1988 • Age: 38 yrs Acquired By Otsuka
Novel therapeutics for CNS disorders are acquired, developed, and commercialized.
Request Access

About Avanir

Avanir is a company based in Aliso Viejo (United States) founded in 1988 was acquired by Otsuka in December 2014.. Avanir operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, Karuna Therapeutics and Kriya Therapeutics, among others.

  • Headquarter Aliso Viejo, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Avanir Pharmaceuticals, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $30 M (USD), Debt – Conventional

    Jun 26, 2012

  • Investors
    SVB

    & 2 more

  • Employee Count
    Employee Count
  • Acquired by
    Otsuka

    (Dec 02, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Avanir
Headcount 1-10
Employee Profiles 80
Board Members and Advisors 17
Employee Profiles
People
Yuko Makino
CFO
People
Tatsuo Higuchi
CEO, President, Representative Director
People
Noriko Tojo
Executive Director
People
Shuichi Takagi
Executive Director

Unlock access to complete

Board Members and Advisors
people
Yoshihisa Aoki
Board Member
people
Ko Sekiguchi
Board Member
people
Ichiro Otsuka
Chairman, Representative Director
people
Hiroshi Sugawara
Board Member

Unlock access to complete

Funding Insights of Avanir

  • Total Funding
  • Total Rounds 1
  • Last Round Debt – Conventional — $30.0M
  • First Round

    (26 Jun 2012)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2012 Amount Debt – Conventional - Avanir Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Avanir

Avanir has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Otsuka and Oxford Finance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture debt firm focused on the life sciences sector
Founded Year Domain Location
Banking services are provided to innovative companies, investors, and individuals.
Founded Year Domain Location
Generic pharmaceuticals and nutraceuticals are manufactured and marketed by Otsuka.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Avanir

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Avanir

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Avanir Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Avanir

Avanir operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, Karuna Therapeutics and Kriya Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Novel biopharmaceutical medicines are developed for unmet medical needs.
domain founded_year HQ Location
Drugs for CNS disorders are developed and advanced.
domain founded_year HQ Location
Genetically engineered cell therapies are developed for multiple disorders.
domain founded_year HQ Location
Therapies for psychosis and cognitive impairment are developed.
domain founded_year HQ Location
Developer of therapeutic solutions for the treatment of diabetes
domain founded_year HQ Location
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Avanir

When was Avanir founded?

Avanir was founded in 1988 and raised its 1st funding round 24 years after it was founded.

Where is Avanir located?

Avanir is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.

Who is the current CEO of Avanir?

Wa El Hashad is the current CEO of Avanir.

What does Avanir do?

Avanir Pharmaceuticals was established in 1988 in Aliso Viejo, United States, as a biopharmaceutical entity. Focus is placed on acquiring, developing, and commercializing treatments for central nervous system disorders. Nuedexta, approved by the FDA for pseudobulbar affect, and Onzetra Xsail, for acute migraine treatment in adults, are marketed. AVP-786 is under clinical development for conditions including Alzheimers disease, depression, and schizophrenia.

Who are the top competitors of Avanir?

Avanir's top competitors include Jazz Pharmaceuticals, Neurocrine and Biohaven Pharmaceutical.

Who are Avanir's investors?

Avanir has 3 investors. Key investors include SVB, Otsuka, and Oxford Finance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available